Date: May 26, 2022
Time: 8:00 AM AEST
Inherited retinal dystrophies (IRD) are a group of diseases characterized by loss of photoreceptors resulting in visual impairment or blindness. IRD are clinically and genetically heterogenous making an accurate diagnosis difficult. Genetic testing for these diseases thus becomes important to confirm the type of IRD. A molecular diagnosis can then potentially provide access to gene specific therapy or allow for entry into interventional clinical trials.
For providers, it can be challenging to know when to order genetic testing and what should be included in the test. In this webinar, Senior Manager of Genomic Services, Kim Gall, MSc, CGC, will review this group of disorders, the genetics of IRD, and how to navigate genetic testing to maximize diagnoses in the clinic.
- Describe the different types of inherited retinal dystrophies
- Demonstrate why genetic testing is important in IRD
- Formulate a process to maximize genetic diagnoses in your clinic
Unable to attend live? By registering, you will receive a link to a recording of the webinar to watch at your convenience.
Sign up for the webinar
Trouble viewing the form? Click here.